The Column Group LLC
- SEC CIK
- 0001833486
- Latest filing
- Aug 14, 2026
Holdings in Q1 2023
Holdings as of Mar 31, 2023, filed May 15, 2023. Long positions only; changes compare share counts with Q4 2022.
- Positions
- 7
- 0 vs. Q4 2022
- Portfolio value
- $276.6M
- −$23.8M (−7.9%) vs. Q4 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,309,329 | $1.52M | 0.5% | 00.0% | Unchanged | History |
| SRZNSurrozen, Inc. | COM | 9,248,129 | $5.57M | 2.0% | −166,666−1.8% | Reduced | History |
| ORICOric Pharmaceuticals, Inc. | COM | 3,568,181 | $20.3M | 7.4% | 00.0% | Unchanged | History |
| TNYATenaya Therapeutics, Inc. | COM | 9,400,290 | $26.8M | 9.7% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 2,680,621 | $49.2M | 17.8% | 00.0% | Unchanged | History |
| NGMNGM Biopharmaceuticals Inc | COM | 18,136,735 | $74.0M | 26.8% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 4,577,840 | $99.2M | 35.9% | 00.0% | Unchanged | History |